Black box warning: Wake-up call or overreaction?

被引：14

作者：

Szefler, SJ

Whelan, GJ

Leung, DYM

机构：

[1] Natl Jewish Med & Res Ctr, Div Pediat Clin Pharmacol, Denver, CO 80206 USA

[2] Natl Jewish Med & Res Ctr, Div Allergy & Immunol, Denver, CO 80206 USA

[3] Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA

[4] Univ Colorado, Hlth Sci Ctr, Denver, CO USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 01期

关键词：

D O I：

10.1016/j.jaci.2005.11.006

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：26 / 29

页数：4

共 8 条

[1] The "black box" warning and allergy drugs [J].

Aaronson, DW .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :40-44

[2] A historical perspective of the New Zealand asthma mortality epidemics [J].

Beasley, R .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :225-228

[3] Report of the topical calcineurin inhibitor task force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology [J].

Fonacier, L ;

Spergel, J ;

Charlesworth, EN ;

Weldon, D ;

Beltrani, V ;

Bernhisel-Broadbent, J ;

Boguniewicz, M ;

Leung, DYM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (06) :1249-1253

[4] Molecular mechanisms of β2-adrenergic receptor function, response, and regulation [J].

Johnson, M .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :18-24

[5] Black box 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk [J].

Murphy, S ;

Roberts, R .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :34-39

[6] Is there a problem with inhaled long-acting β-adrenergic agonists? [J].

Nelson, HS .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :3-16

[7] Primum non nocere and "black box" warnings [J].

Pearlman, DS .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :30-31

[8]

*US FDA, 2005, MED OFF REV PROV M P

← 1 →